Blade Therapeutics
South San Francisco
About Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company. Their mission is to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Their leadership team has extensive experience at developing drugs that treat fibrotic disorders. They are also partnering with international experts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $51.5M
- Last round: Series Unknown (Nov 2018)
- Website: blademed.com
- Phone: +1 650 278 4291
Industries & Categories
Biopharma, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/blade-therapeutics-74257 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.